Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Around the PracticeBetween the LinesFace OffFrom All AnglesMeeting of the MindsOncViewPodcastsTraining AcademyTreatment Algorithms with the Oncology BrothersVideos
Conferences
All JournalsEditorial BoardFor AuthorsYear in Review
Frontline ForumSatellite Sessions
CME/CE
Awareness MonthNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career CenterSubscribe
Adverse Effects
Brain Cancer
Breast CancerBreast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head & Neck Cancer
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
InfectionInfection
Leukemia
Lung CancerLung CancerLung Cancer
Lymphoma
Neuroendocrine Tumors
Oncology
Pediatric Cancers
Radiation Oncology
Sarcoma
Screening
Skin Cancer & Melanoma
Surgery
Thyroid Cancer
Spotlight -
  • Radiation Oncology
  • Surgery
Adverse Effects
Brain Cancer
Breast CancerBreast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head & Neck Cancer
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
InfectionInfection
Leukemia
Lung CancerLung CancerLung Cancer
Lymphoma
Neuroendocrine Tumors
Oncology
Pediatric Cancers
Radiation Oncology
Sarcoma
Screening
Skin Cancer & Melanoma
Surgery
Thyroid Cancer
    • Conferences
    • CME/CE
    • Career Center
    • Subscribe
Advertisement

Trends in Oncology from ACCC Annual Report Reveal ‘Silver Lining’ of the Pandemic

May 26, 2021
By Audrey Sternberg
Article

The 2020 Trending Now in Cancer report highlighted a shift in oncology care resulting from the COVID-19 pandemic.

Results from the Association of Community Cancer Centers’ (ACCC) annual report, Trending Now in Cancer Care 2020, reveal the extent of the COVID-19 pandemic on cancer care and oncology professionals.

Straying from the organization’s typical structure of conducting surveys for the report, the team at ACCC conducted focus groups in 2020 to better understand the experiences of health care providers. This decision was made due to the high demands on multidisciplinary care providers over the previous year. Topics discussed included staffing and operational integrity, service line delivery and revenue optimization, telehealth and supportive technology, clinical research, and health equity.

“This report is critically important and unlike any other, in that we are able to identify the impact of the pandemic on cancer programs and their staff, and tailor our resources to incorporate the lessons learned over the past year,” Krista Nelson, MSW, LCSW, OSW-C, FAOSW, who is ACCC President and Program Manager of Quality and Research, Cancer Support Services & Compassion for the Providence Cancer Institute in Portland, Oregon, said in a press release. “Feedback from members reaffirmed ACCC’s commitment to focus on education and resources to promote equity, diversity, and inclusion within oncology, and build a culture of resilience for cancer care staff.”

As expected, findings of the survey showed that COVID-19 weighed heavily on providers in the oncology space. Factors contributing to the added stress ranged widely and included financial hardships from layoffs, exhaustion from burnout, and the emotional toll of social distancing measures. Managers and leaders reported that the added burden of caring for the needs of their staff was a “full-time occupation”.

In line with available research indicating that the pandemic led to a drop in cancer screenings, the focus groups confirmed that their experiences matched the findings of investigators. Adding to that, many reported that necessary screening measures have not resumed to pre-pandemic levels. As such, participants surmised that more advanced cancers at diagnosis are likely to be recorded in 2021 and beyond.

Reduced or suspended services and the overall reduction in patient volume adversely impacted revenue to the health care system. However, since oncologic services such as chemotherapy infusions and radiation treatments remained steady during the early months of the pandemic, cancer programs served to financially “shore up” the health care institutions whose other service lines diminished care.

A more robust telehealth structure emerged as a welcomed side effect of the pandemic, accounting for between 40% to 50% of patient volume in 2020. However, greater reliance on these methods of communication has created a “digital divide” where certain patients, especially those in rural areas where cell phone service and connectivity are lacking, do not have equal access.

Exacerbated by the presence of the virus, health disparities in general and those specific to oncology came to the forefront. Socioeconomic, racial and ethnic, age, gender and geographic divides are served to aggravate health outcomes, which in turn motivated cancer programs across the country to act. New efforts like extending office hours, assisting patients with transportation, and partnering with community organizations were implemented to assist those who had difficulty accessing needed care. In addition, ACCC reported that added flexibilities in clinical research have the potential to positively impact the conduct of clinical trials in the long term, which may result in untold benefits to providers and their patients.

Ultimately, the findings revealed “silver linings” to come from the disruptions of the pandemic, with focus group participants reporting “how their cancer programs and practices developed new operational approaches and workflows to minimize disruptions to staff and patients and ensure continuity of care.”

References

1. Trending now in cancer care. Association of Community Cancer Centers. May 2020. Accessed May 26, 2021. https://bit.ly/3hSG2XF

2. Association of Community Cancer Centers Releases Report: Trending Now in Cancer Care 2020. News release. Association of Community Cancer Centers. May 24, 2021. Accessed May 26, 2021. https://bit.ly/3hUpuyh

Recent Videos
Trials at scale can be conducted in middle-income, low-middle-income, and even lower-income countries if you organize a trial ecosystem.
For example, you have a belt of certain diseases or genetic disorders that you come across, such as sickle cell disease or thalassemia, that are more prevalent in these areas.
Talent shortages in the manufacturing and administration of cellular therapies are problems that must be addressed at the level of each country.
Point-of-care manufacturing, scalable manufacturing, and bringing the cost down [can help].
A novel cancer database may assist patients determine what clinical trials they are eligible to enroll on and identify the next best steps for treatment.
A consolidated database may allow providers to access information on a patient’s prior treatments and genetic abnormalities all in 1 place.
A study presented at ASTRO 2025 evaluated the feasibility of using a unified cancer database to consolidate information gathered across 14 institutions.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to look forward to at the 2025 ESMO Annual Congress, from hot topics and emerging trends to travel recommendations.
Physical therapists may play a key role in patient care before, during, and after treatment for cancer, according to Alison Ankiewicz, PT, DPT.
Related Content
Advertisement

Explore how oncogenes and signaling pathways converge and diverge in cancer, shaping diagnostic and therapeutic strategies for personalized interventions.

Convergent and Divergent Signaling Pathways in Cancer: A Dual-Axis Model for Adaptive Precision Oncology

Aliasgar Shahiwala, PhD
October 25th 2025
Article

Explore how oncogenes and signaling pathways converge and diverge in cancer, shaping diagnostic and therapeutic strategies for personalized interventions.


Experts discuss key considerations for applying ctDNA to clinical practice, such as distinguishing between tumor-informed and tumor-uninformed testing.

Diving Into the Practical Applications of ctDNA in Oncology Care

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;Arnab Basu, MBBS, MPH, FACP
September 25th 2025
Podcast

Experts discuss key considerations for applying ctDNA to clinical practice, such as distinguishing between tumor-informed and tumor-uninformed testing.


Medical Conference Forum Latest Advances in Healthcare | © Purnomo-Adobe Stock

The Fellow's Playbook: How to Make the Most of Your First Oncology Meeting

Ariana Pelosci
October 21st 2025
Article

Third-year fellows from Weill Cornell Medicine offer 7 key tips for establishing a foundational understanding of the field at major oncology meetings.


How to Discuss Death: A Conversation of Mortality in Cancer Care

How to Discuss Death: A Conversation of Mortality in Cancer Care

Daniel C. McFarland, DO;William Breitbart, MD
September 22nd 2025
Podcast

Daniel C. McFarland, DO; and guest William S. Breitbart, MD, discuss the critical role of meaning-centered therapy in addressing the psychosocial needs of patients with cancer.


Pimicotinib Yields Long-Term Response in Tenosynovial Giant Cell Tumor

Pimicotinib Yields Long-Term Response in Tenosynovial Giant Cell Tumor

Chris Ryan
October 18th 2025
Article

Pimicotinib shows promising long-term efficacy and safety for treating tenosynovial giant cell tumor, offering significant patient benefits in a recent trial.


Proactive disclosure of information by clinical social workers in oncology may help equip patients to handle difficult aspects of cancer treatment.

Explicating The Valuable Role of Clinical Social Work in Oncology

Roman Fabbricatore
October 17th 2025
Article

Proactive disclosure of information by clinical social workers in oncology may help equip patients to handle difficult aspects of cancer treatment.

Related Content
Advertisement

Explore how oncogenes and signaling pathways converge and diverge in cancer, shaping diagnostic and therapeutic strategies for personalized interventions.

Convergent and Divergent Signaling Pathways in Cancer: A Dual-Axis Model for Adaptive Precision Oncology

Aliasgar Shahiwala, PhD
October 25th 2025
Article

Explore how oncogenes and signaling pathways converge and diverge in cancer, shaping diagnostic and therapeutic strategies for personalized interventions.


Experts discuss key considerations for applying ctDNA to clinical practice, such as distinguishing between tumor-informed and tumor-uninformed testing.

Diving Into the Practical Applications of ctDNA in Oncology Care

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;Arnab Basu, MBBS, MPH, FACP
September 25th 2025
Podcast

Experts discuss key considerations for applying ctDNA to clinical practice, such as distinguishing between tumor-informed and tumor-uninformed testing.


Medical Conference Forum Latest Advances in Healthcare | © Purnomo-Adobe Stock

The Fellow's Playbook: How to Make the Most of Your First Oncology Meeting

Ariana Pelosci
October 21st 2025
Article

Third-year fellows from Weill Cornell Medicine offer 7 key tips for establishing a foundational understanding of the field at major oncology meetings.


How to Discuss Death: A Conversation of Mortality in Cancer Care

How to Discuss Death: A Conversation of Mortality in Cancer Care

Daniel C. McFarland, DO;William Breitbart, MD
September 22nd 2025
Podcast

Daniel C. McFarland, DO; and guest William S. Breitbart, MD, discuss the critical role of meaning-centered therapy in addressing the psychosocial needs of patients with cancer.


Pimicotinib Yields Long-Term Response in Tenosynovial Giant Cell Tumor

Pimicotinib Yields Long-Term Response in Tenosynovial Giant Cell Tumor

Chris Ryan
October 18th 2025
Article

Pimicotinib shows promising long-term efficacy and safety for treating tenosynovial giant cell tumor, offering significant patient benefits in a recent trial.


Proactive disclosure of information by clinical social workers in oncology may help equip patients to handle difficult aspects of cancer treatment.

Explicating The Valuable Role of Clinical Social Work in Oncology

Roman Fabbricatore
October 17th 2025
Article

Proactive disclosure of information by clinical social workers in oncology may help equip patients to handle difficult aspects of cancer treatment.

Advertisement
About
Advertise
CureToday.com
OncLive.com
OncNursingNews.com
TargetedOnc.com
Editorial
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.